Regulatory Context Sample Clauses

Regulatory Context. The focus in this section is to identify the environmental and land use authorizations, permits and approvals necessary to enable the necessary works for the Donkin Underground Exploration Project. Requirements of the various levels of government for approvals, authorizations and permits are identified.
View Source
Regulatory Context. The Halifax Regional Municipality Charter provides Council with a mechanism to discharge development agreements. Part VIII, Section 244 of the Charter empowers Council to discharge a development agreement, in whole or in part, in accordance with the terms of the agreement or with the concurrence of the property owner. The Charter does not require a public hearing for the discharge of an agreement or a portion thereof. A Community Council may discharge a development agreement by resolution. If the existing development agreement is discharged, future development on the subject site would be controlled by the R-1 zone standards in the Land Use By-law for Halifax Mainland.
View Source
Regulatory Context. The proposed Project is considered a federal undertaking4 subject to compliance with Section 106 of the NHPA of 1966, as amended, and its implementing regulations found in 36 CFR Part 800. Section 106 requires federal agencies to take into account the effects of their undertakings on historic properties (36 CFR 800.1[a]). Historic properties are any prehistoric or historic district, site, building, structure, object, or traditional cultural property included in or eligible for inclusion in the National Register of Historic Places (National Register; 36 CFR 800.16(l)(1)). In addition to Section 106, the Project is also required to adhere to other environmental and cultural resources regulatory requirements, including, but not limited to, the National Environmental Policy Act (NEPA), the Archaeological Resources Protection Act (ARPA), the American Indian Religious Freedom Act, the Native American ▇▇▇▇▇▇ Protection and Repatriation Act (NAGPRA), Executive Order 11593 (Protection and Enhancement of the Cultural Environment), the American Antiquities Act of 1906, Executive Order 13007 (Indian Sacred Sites), and Executive Order 13175 (Consultation and Coordination with Indian Tribal Governments).
View Source
Regulatory Context. This HPTP has been developed to assist the BLM in their compliance with Section 106 of the National Historic Preservation Act (NHPA), the California Environmental Quality Act (CEQA; PRC 21000 - 21177), and other applicable federal, state, and/or local laws, ordinances, rules, regulations, and policies. Pursuant to 36 CFR § 800, the regulations implementing the NHPA, an MOA has been developed for OWEF Project. Stipulation III of the MOA and Mitigation Measure CUL-4 of the ▇▇▇▇ require the development of a Historic Property Treatment Plan (HPTP) for the project. This document is responsive to these stipulations.
View Source
Regulatory Context. This HPTP has been developed to assist the BLM in their compliance with Section 106 of the National Historic Preservation Act (NHPA), and other applicable federal, state, and/or local laws, ordinances, rules, regulations, and policies. Pursuant to 36 CFR § 800, the regulations implementing the NHPA, an MOA has been developed for Project. Stipulation III of the MOA and Mitigation Measure CUL-4 of the FEIS require the development of a HPTP for the project. This document is responsive to these stipulations.
View Source
Regulatory Context. Scope of the BDCP
View Source

Related to Regulatory Context

  • Regulatory Cooperation In connection with any foreclosure, collection, sale or other enforcement of Liens granted to the Administrative Agent in the Collateral Documents, Parent will, and will cause its Restricted Subsidiaries to, reasonably cooperate in good faith with the Administrative Agent or its designee in obtaining all regulatory licenses, consents and other governmental approvals necessary or (in the reasonable opinion of the Administrative Agent or its designee) reasonably advisable to conduct all aviation operations with respect to the Collateral and will, at the reasonable request of the Administrative Agent and in good faith, continue to operate and manage the Collateral and maintain all applicable regulatory licenses with respect to the Collateral until such time as the Administrative Agent or its designee obtain such licenses, consents and approvals, and at such time Parent will, and will cause its Restricted Subsidiaries to, cooperate in good faith with the transition of the aviation operations with respect to the Collateral to any new aviation operator (including, without limitation, the Administrative Agent or its designee).

  • Regulatory Materials (a) On a Program-by-Program basis, commencing on the Effective Date until the Regulatory Transfer Date, Prothena shall have the right, in consultation with Celgene, to prepare, file and maintain all Regulatory Materials (including any Regulatory Approvals) necessary for the Development and Manufacture of any Collaboration Candidates and Collaboration Products for such Program (collectively, the “Program Regulatory Materials”), and to interact with Regulatory Authorities in connection with the Development and Manufacture of any Collaboration Candidates and Collaboration Products for such Program. Prothena will provide Celgene with a reasonable opportunity to comment substantively on all material Regulatory Materials prior to filing or taking material action, and will reasonably and in good faith consider any comments and actions recommended by Celgene, including with respect to filing strategy. In addition, Prothena will allow Celgene or its representative to attend any and all meetings with Regulatory Authorities to the extent such attendance is not prohibited or limited by such Regulatory Authority. (b) If Celgene exercises its Phase 1 Portion Participation Right for a given Program, then immediately after such exercise, Prothena shall initiate the transfer of all Program Regulatory Materials, including for clarity any IND for the relevant Collaboration Candidates and/or Collaboration Products that are the subject of such Program to Celgene. The date on which such Program Regulatory Materials are transferred to Celgene shall be the “Regulatory Transfer Date” for such Program. Thereafter, Celgene shall have the right, in consultation with Prothena, to prepare, file, and maintain such Program Regulatory Materials, and to interact with Regulatory Authorities in connection with the Development and, as applicable, Manufacture of such Collaboration Candidates and Collaboration Products for such Program in accordance with the terms and conditions of Section 2.5. Additionally, with respect to any Phase 1 Clinical Trial conducted by Celgene pursuant to Section 2.5, Celgene will provide Prothena with a reasonable opportunity to comment substantively on all material Program Regulatory Materials prior to filing or taking material action, and will reasonably and in good faith consider any comments and actions recommended by Prothena, including with respect to filing strategy. In addition, with respect to any Phase 1 Clinical Trial conducted by Celgene pursuant to Section 2.5, Celgene will allow Prothena or its representative to attend any and all meetings with Regulatory Authorities to the extent such attendance is not prohibited or limited by such Regulatory Authority. For clarity, if the Regulatory Transfer Date does not occur prior to the expiration of the Option Term for such Program, Section 2.6.1(a) (and not this Section 2.6.1(b)) shall apply.

  • Regulatory References A reference in this Agreement to a section in the HIPAA Rules means the section as in effect or as amended.

  • Regulatory Consents The waiting period applicable to the consummation of the Merger under the HSR Act shall have expired or been earlier terminated.

  • Regulatory Applications (a) Summit and GAFC and their respective Subsidiaries shall cooperate and use their respective reasonable best efforts to prepare all documentation, to effect all filings and to obtain all permits, consents, approvals and authorizations of all third parties and Governmental Authorities necessary to consummate the transactions contemplated by this Agreement. Each of Summit and GAFC shall have the right to review in advance, and to the extent practicable each will consult with the other, in each case subject to applicable laws relating to the exchange of information, with respect to, all material written information submitted to any third party or any Governmental Authority in connection with the transactions contemplated by this Agreement. In exercising the foregoing right, each of the parties hereto agrees to act reasonably and as promptly as practicable. Each party hereto agrees that it will consult with the other party hereto with respect to the obtaining of all material permits, consents, approvals and authorizations of all third parties and Governmental Authorities necessary or advisable to consummate the transactions contemplated by this Agreement and each party will keep the other party apprised of the status of material matters relating to completion of the transactions contemplated hereby. (b) Each party agrees, upon request, to furnish the other party with all information concerning itself, its Subsidiaries, directors, officers and stockholders and such other matters as may be reasonably necessary or advisable in connection with any filing, notice or application made by or on behalf of such other party or any of its Subsidiaries to any third party or Governmental Authority.